Baseline characteristics
| ALLO (n=28) | CONT (n=25)* | p | |
|---|---|---|---|
| Gestational age (weeks, days) | 40.0 (37.0–41.4) | 39.6 (36.0–42.0) | 0.253 |
| Birthweight (g) | 3500 (2425–5270) | 3240 (2300–4720) | 0.747 |
| Cord pH | 6.90 (6.49–7.05) | 6.94 (6.60–7.15) | 0.112 |
| Apgar score at 5 min | 4 (2–7) | 4 (1–8) | 0.471 |
| aEEG | |||
| CNV, n (%) | 8 (29%) | 5 (20%) | 0.405 |
| BS, n (%) | 8 (29%) | 12 (48%) | 0.371 |
| CLV, n (%) | 2 (7%) | 4 (16%) | 0.414 |
| FT, n (%) | 10 (36%) | 4 (16%) | 0.109 |
Data are reported as median (range), unless otherwise stated.
↵* One child was excluded because of a suspected syndrome.
ALLO, allopurinol; BS, burst suppression; CLV, continuous low voltage; CNV, continuous normal voltage; CONT, controls; FT, flat trace.